Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0920-2017

Drug recall · June 21, 2017

Montelukast Sodium Oral Granules recall

Why: Failed Impurities/Degradation Specifications; out of specification results for Sulphoxide Impurity and Total Impurities

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Montelukast Sodium Oral Granules, 4 mg pouch, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-6040-93

Lots / codes

Batch 3074707, exp 02/2018

Quantity
11,624 pouches
Company
Mylan Pharmaceuticals Inc., Morgantown, WV
Distribution
Nationwide
Initiated
May 9, 2017 · Voluntary: Firm initiated
Classified
June 15, 2017
Reported
June 21, 2017
Ended
February 14, 2018
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Montelukast

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.